We are live on ! Find out more
CDH

Charles D. Hyman Portfolio holdings

AUM $1.79B
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
-1.15%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$598M
AUM Growth
+$4.34M
Cap. Flow
+$14.9M
Cap. Flow %
2.48%
Top 10 Hldgs %
30.1%
Holding
158
New
7
Increased
41
Reduced
57
Closed
10

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$6.32M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.35M
3
NSC icon
Norfolk Southern
NSC
+$2.26M
4
F icon
Ford
F
+$1.97M
5
MET.PRA icon
MetLife Inc Floating Rate Series A
MET.PRA
+$1.2M

Top Sells

Rank Stock Value
1
RD
ROYAL DUTCH PET (NEW)1.25GLDRS
RD
+$1.06M
2
JNJ icon
Johnson & Johnson
JNJ
+$437K
3
GLD icon
SPDR Gold Trust
GLD
+$364K
4
VOD icon
Vodafone
VOD
+$327K
5
ANAT
American National Group, Inc. Common Stock
ANAT
+$269K

Sector Composition

Rank Sector Weight
1 Industrials 19.18%
2 Consumer Staples 11.02%
3 Healthcare 10.93%
4 Energy 9.93%
5 Financials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
126
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$237K 0.04%
+1,201
New +$237K
CI icon
127
Cigna
CI
$76.6B
$236K 0.04%
2,600
-600
-19% -$56.1K
LOW icon
128
Lowe's Companies
LOW
$116B
$228K 0.04%
4,300
-300
-7% -$15.2K
POT
129
DELISTED
Potash Corp Of Saskatchewan
POT
$225K 0.04%
6,500
-1,400
-18% -$49.6K
NCV
130
Virtus Convertible & Income Fund
NCV
$374M
$222K 0.04%
5,805
-125
-2% -$5.04K
POM
131
DELISTED
PEPCO HOLDINGS, INC.
POM
$216K 0.04%
+8,087
New +$220K
ED icon
132
Consolidated Edison
ED
$41.6B
$211K 0.04%
3,720
+6
+0.2% +$341
GOOG icon
133
Alphabet (Google) Class C
GOOG
$3.9T
$210K 0.04%
+7,280
New +$211K
AFL icon
134
Aflac
AFL
$63.9B
$209K 0.04%
7,160
– –
NWBO
135
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$208K 0.03%
41,375
– –
SJM icon
136
J.M. Smucker
SJM
$12.6B
$204K 0.03%
2,060
-212
-9% -$21.8K
K
137
DELISTED
Kellanova
K
$200K 0.03%
3,461
– –
OPK icon
138
Opko Health
OPK
$921M
$141K 0.02%
16,619
– –
SONN
139
DELISTED
Sonnet BioTherapeutics
SONN
– –
0
– –
GNMX
140
DELISTED
Aevi Genomic Medicine Inc
GNMX
$75K 0.01%
14,500
– –
HOTRW
141
DELISTED
CHANTICLEER HLDGS INC WTS EXP 6/11/2017 (DE)
HOTRW
$13K ﹤0.01%
44,444
– –
EOG icon
142
EOG Resources
EOG
$78B
– –
-2,000
Closed -$234K
PRA
143
DELISTED
ProAssurance
PRA
– –
-5,268
Closed -$234K
RF icon
144
Regions Financial
RF
$26.3B
– –
-10,090
Closed -$107K
PCL
145
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
– –
-4,592
Closed -$207K
GSX
146
DELISTED
GASCO ENERGY INC
GSX
– –
-10,000
Closed –
CNB
147
DELISTED
COLONIAL BANCGROUP INC
CNB
$0 ﹤0.01%
27,979
– –
RD
148
DELISTED
ROYAL DUTCH PET (NEW)1.25GLDRS
RD
– –
-12,913
Closed -$1.06M
2 3 4 5
6

Similar funds

AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Charles D. Hyman's Q3 2014 Portfolio in Review

As of Q3 2014, Charles D. Hyman held 158 positions worth $598M, up 0.73% from $594M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Charles D. Hyman's Q3 2014 filing shows 7 new, 41 increased, 57 reduced and 10 closed positions. Its largest new stake was Altria Group: 147,493 shares worth $6.78M. The largest sale was ROYAL DUTCH PET (NEW)1.25GLDRS, an estimated $1.06M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 19% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Charles D. Hyman's largest Q3 2014 buy was Altria Group: 147,493 shares worth $6.78M.
  • Charles D. Hyman added most to Berkshire Hathaway Class B in Q3 2014, an estimated $2.35M increase.
  • Charles D. Hyman's biggest Q3 2014 reduction was Johnson & Johnson, cutting an estimated $437K.
  • Charles D. Hyman fully exited ROYAL DUTCH PET (NEW)1.25GLDRS in Q3 2014, selling an estimated $1.06M.
  • Charles D. Hyman's ten largest holdings make up 30% of its $598M portfolio in Q3 2014.
  • Charles D. Hyman opened 7 new positions and closed 10 in Q3 2014.
  • Charles D. Hyman's portfolio value rose 0.73% quarter-over-quarter to $598M.

Based on Charles D. Hyman's 13F filing for Q3 2014, filed 30 Oct 2014.